Share this to:

Support & Insight for the Autumn of Life

WSJ: Rember Tackles the Tau behind Alzheimer’s

VIDEO

Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’ Alzheimer’s trial drug called Rember.

WSJ’s Shirley Wang spoke with Dr. Wischik about his work on this new drug to treat the devastating disease.



Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
B. Berger

B. Berger

Visit Our Pages On:

Welcome

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Related

150322-MayoDia.jpeg
The Mayo Clinic's Better Way to Test Dementia
Some Alzheimer’s tests cost thousands of dollars, some cost pennies. The trick is using the right tests at the right ...
person holding hearing aid
How Hearing Loss is Linked to Cognitive Decline
A doctor who specializes in geriatric medicine explains how hearing devices can be helpful in preventing long-term co...
130526-skincancer.jpeg
Why Don't Skin Cancer Patients Get Alzheimer's?
80% fewer skin-cancer patients get Alzheimer's. Why? Is it the medicines they take, their genes, or are they more pro...

Books

Amazon Books
0
Would love your thoughts, please comment.x
()
x
News to Get at the Truth

Subscribe To Our Weekly Newsletter

Enjoy thought-provoking videos & articles
News to Get at the Truth

Subscribe To Our Weekly Newsletter